FARN — Faron Pharmaceuticals Oy Share News
0.000.00%
HealthcareSpeculativeSmall CapMomentum Trap
- £218.61m
- £224.83m
REG - Faron Pharma. Oy - Notice of Faron Pharmaceuticals Ltd’s AGM
AnnouncementREG - Faron Pharma. Oy - Financial Statement January 1 to December 31 2021
AnnouncementREG - Faron Pharma. Oy - Faron´s Annual Report 2021 Published
AnnouncementRCS - Faron Pharma. Oy - Faron Publishes Research From INTEREST Trial
AnnouncementRCS - Faron Pharma. Oy - Presentation of Biomarker Data at AACR 2022
AnnouncementRCS - Faron Pharma. Oy - Notice of 2021 Full-Year Results and Annual Report
AnnouncementRCS - Faron Pharma. Oy - Faron presents at upcoming conferences
AnnouncementREG - Faron Pharma. Oy - Faron Board Issues Warrants to IPF Partners
AnnouncementREG - Faron Pharma. Oy - Faron Obtains Debt Funding from IPF Partners
AnnouncementREG - Faron Pharma. Oy - Faron Updates on Bexmarilimab Development Program
AnnouncementREG - Faron Pharma. Oy - Faron Announces R&D Day
AnnouncementREG - Faron Pharma. Oy - Scientific Reports Publishes INFORAAA Results
AnnouncementREG - Faron Pharma. Oy - Holdings in Company
AnnouncementREG - Faron Pharma. Oy - Juho Jalkanen Appointed Chief Operating Officer
AnnouncementREG - Faron Pharma. Oy - Grant of options
AnnouncementRCS - Faron Pharma. Oy - Faron at Proactive One2One Investor Forum
AnnouncementRCS - Faron Pharma. Oy - Faron to Present at Redeye Fight Cancer Seminar
AnnouncementRCS - Faron Pharma. Oy - Faron to Present at H.C. Wainwright BioConnect
AnnouncementREG - Faron Pharma. Oy - Faron Appoints Marie-Louise Fjällskog as CMO
Announcement